Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Bronte

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Seminars in Oncology|January 21, 2025
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?Giuseppe Bronte
International Journal of Molecular Sciences|July 2, 2021
TMB in NSCLC: A Broken Dream?Sara Bravaccini, Giuseppe Bronte, Paola Ulivi
Critical Reviews in Oncology/Hematology|May 7, 2022
The application of cancer stem cell model in malignant mesotheliomaGiuseppe Bronte, Antonio Domenico Procopio, Laura Graciotti
Expert Opinion on Biological Therapy|March 29, 2014
How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?Giuseppe Bronte, Christian Rolfo, Marc Peeters, et al.
Expert Opinion on Biological Therapy|August 4, 2015
Anti-angiogenic drugs for second-line treatment of NSCLC patients: just new pawns on the chessboard?Giuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2022
Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysisGiuseppe Bronte, Vincenza Conteduca, Matteo Landriscina, et al.
Expert Opinion on Therapeutic Targets|July 16, 2013
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targetingChristian Rolfo, Antonio Russo, Daniele Santini, et al.
Clinical and Experimental Medicine|November 19, 2022
The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysisGiuseppe Bronte, Luana Calabrò, Fabiola Olivieri, et al.
Critical Reviews in Oncology/Hematology|January 19, 2016
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysisFrancesco Passiglia, Giuseppe Bronte, Viviana Bazan, et al.
Lung Cancer (Auckland, N.Z.)|April 10, 2019
Targeting RET-rearranged non-small-cell lung cancer: future prospectsGiuseppe Bronte, Paola Ulivi, Alberto Verlicchi, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Seminars in Oncology|January 21, 2025
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?Giuseppe Bronte
International Journal of Molecular Sciences|July 2, 2021
TMB in NSCLC: A Broken Dream?Sara Bravaccini, Giuseppe Bronte, Paola Ulivi
Critical Reviews in Oncology/Hematology|May 7, 2022
The application of cancer stem cell model in malignant mesotheliomaGiuseppe Bronte, Antonio Domenico Procopio, Laura Graciotti
Expert Opinion on Biological Therapy|March 29, 2014
How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?Giuseppe Bronte, Christian Rolfo, Marc Peeters, et al.
Expert Opinion on Biological Therapy|August 4, 2015
Anti-angiogenic drugs for second-line treatment of NSCLC patients: just new pawns on the chessboard?Giuseppe Bronte, Francesco Passiglia, Antonio Galvano, et al.
Prostate Cancer and Prostatic Diseases|November 21, 2022
Circulating myeloid-derived suppressor cells and survival in prostate cancer patients: systematic review and meta-analysisGiuseppe Bronte, Vincenza Conteduca, Matteo Landriscina, et al.
Expert Opinion on Therapeutic Targets|July 16, 2013
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targetingChristian Rolfo, Antonio Russo, Daniele Santini, et al.
Clinical and Experimental Medicine|November 19, 2022
The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysisGiuseppe Bronte, Luana Calabrò, Fabiola Olivieri, et al.
Critical Reviews in Oncology/Hematology|January 19, 2016
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysisFrancesco Passiglia, Giuseppe Bronte, Viviana Bazan, et al.
Lung Cancer (Auckland, N.Z.)|April 10, 2019
Targeting RET-rearranged non-small-cell lung cancer: future prospectsGiuseppe Bronte, Paola Ulivi, Alberto Verlicchi, et al.
Pageof 11